Literature

Search Literature

You can search and request for digital copy(ies) of literature listed below. Your request will be processed within 5-10 business days. (You need to log in to request literature copies.) To read the abstracts, click on the DOI Link button.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to request literature copies.

Select the literature you wish to request a copy of. To read the abstracts, click on teh DOI Link button.

41 Results Found

  1. 10
  2. 20
  3. 30
  4. All
  1. Development of small-scale models to understand the impact of continuous downstream bioprocessing on integrated virus filtration

    Author
    Scott Lute, Julie Kozaili, et al.
    Organization
    U.S. FDA, Asahi Kasei Medical Co., Ltd.
    Journal
    Biotechnol Progress
    Year
    2020
    Access
    Open
  2. Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles

    Author
    Adan-Kubo, J., et al.
    Organization
    Japanese Blood Products Organization, Asahi Kasei Medical Co., Ltd.
    Journal
    Biotechnol Progress.2019;35:e2875
    Year
    2019
    Access
    Open
  3. The Role of Nanofiltration in the Pathogen Safety of Biologicals: An Update

    Author
    Inouye, M. and Burnouf, T.
    Organization
    M.I.: Asahi Kasei Medical Co., Ltd., T.B.: Taipei Medical University
    Journal
    Current Nanoscience, 2019, 15, 1-10
    Year
    2019
    Access
    Abstract Only
  4. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products

    Author
    Yue, C., et al.
    Organization
    Paul-Ehrlich-Institut, Asahi Kasei, Instituto Oswaldo Cruz
    Journal
    Viruses. 2019 Mar; 11(3): 234.
    Year
    2019
    Access
    Open
  5. Use of a noninfectious surrogate to predict minute virus of mice removal during nanofiltration

    Author
    Cetlin, D., et al
    Organization
    MockV Solutions, Inc.
    Journal
    Biotechnology Progress 34(5) pp.1113-1220
    Year
    2018
    Access
    Abstract Only
  6. Inactivation and removal of Zika virus during manufacture of plasma‐derived medicinal products

    Author
    Blumel, J. et al
    Organization
    Paul-Ehrlich-Institut
    Journal
    Transfusion 2017 (57) 790-796
    Year
    2017
    Access
    Open
  7. cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate

    Author
    Dey, A., et al
    Organization
    International AIDS Vaccine Initiative, Department of Microbiology and Immunology, et al
    Journal
    Biotechnology and Bioengineering 2018 (115) 885–899
    Year
    2018
    Access
    Open
  8. Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives

    Author
    Yunoki, M., et al
    Organization
    Japan Blood Products Organization
    Journal
    Biologicals 44(5) 403-411
    Year
    2016
    Access
    Abstract Only
  9. Pathogen safety of a pasteurized four‐factor human prothrombin complex concentrate preparation using serial 20N virus filtration

    Author
    Nowak, T., et al
    Organization
    CSL Behring
    Journal
    Transfusion 57(5) 1184-1191
    Year
    2017
    Access
    Open
  10. Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid

    Author
    Radomski, K., et al
    Organization
    Octapharma Biopharmaceuticals GmbH
    Journal
    BioDrugs (2017) 31: 125
    Year
    2017
    Access
    Open